Autodesk, Inc. |
|
|
| ||||
Condensed Consolidated Statements of Cash Flows |
|
|
| ||||
(In millions) |
|
|
| ||||
|
|
|
| ||||
| Nine Months Ended October 31, | ||||||
| 2021 |
| 2020 | ||||
| (Unaudited) | ||||||
Operating activities: |
|
|
| ||||
Net income | $ | 407.9 |
|
| $ | 296.9 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| ||||
Depreciation, amortization and accretion | 113.9 |
|
| 92.2 |
| ||
Stock-based compensation expense | 409.8 |
|
| 291.5 |
| ||
Deferred income taxes | 15.4 |
|
| 13.0 |
| ||
Other | 13.1 |
|
| 48.6 |
| ||
Changes in operating assets and liabilities, net of business combinations: |
|
|
| ||||
Accounts receivable | 70.0 |
|
| 112.8 |
| ||
Prepaid expenses and other assets | (138.8) |
|
| (61.6) |
| ||
Accounts payable and other liabilities | (67.4) |
|
| 42.3 |
| ||
Deferred revenue | (28.4) |
|
| (78.3) |
| ||
Accrued income taxes | 13.0 |
|
| 22.2 |
| ||
Net cash provided by operating activities | 808.5 |
|
| 779.6 |
| ||
Investing activities: |
|
|
| ||||
Purchases of marketable securities | (56.5) |
|
| (21.0) |
| ||
Sales and maturities of marketable securities | 4.0 |
|
| 17.0 |
| ||
Capital expenditures | (49.5) |
|
| (67.6) |
| ||
Purchases of developed technologies | (9.6) |
|
| (4.8) |
| ||
Business combinations, net of cash acquired | (1,185.1) |
|
| (44.8) |
| ||
Other investing activities | (2.3) |
|
| (55.5) |
| ||
Net cash used in investing activities | (1,299.0) |
|
| (176.7) |
| ||
Financing activities: |
|
|
| ||||
Proceeds from issuance of common stock, net of issuance costs | 113.3 |
|
| 112.9 |
| ||
Taxes paid related to net share settlement of equity awards | (147.8) |
|
| (105.0) |
| ||
Repurchases of common stock | (482.7) |
|
| (399.4) |
| ||
Proceeds from debt, net of discount | 997.0 |
|
| — |
| ||
Repayment of debt | — |
|
| (450.0) |
| ||
Other financing activities | (6.5) |
|
| (2.5) |
| ||
Net cash provided by (used in) financing activities | 473.3 |
|
| (844.0) |
| ||
Effect of exchange rate changes on cash and cash equivalents | (6.1) |
|
| 3.4 |
| ||
Net decrease in cash and cash equivalents | (23.3) |
|
| (237.7) |
| ||
Cash and cash equivalents at beginning of period | 1,772.2 |
|
| 1,774.7 |
| ||
Cash and cash equivalents at end of period | $ | 1,748.9 |
|
| $ | 1,537.0 |
|
|
|
|
| ||||
Supplemental cash flow disclosure: |
|
|
| ||||
Non-cash financing activities: |
|
|
| ||||
Fair value of common stock issued to settle liability-classified restricted stock units | $ | 2.7 |
|
| $ | 28.7 |
|
Fair value of common stock issued related to business combination | $ | 2.6 |
|
| $ | — |
|